Antibodies
We have generated monoclonal antibodies against several antigens and cell types. These antibodies are available for commercialization and for collaborative research projects. sroff@ibms.sinica.edu.tw for more information.
Name | Antigen | Subclass | Comments |
AFP3.3 | human AFP | IgG2a | Binds to epitope 1 of AFP |
1E8-E7-A11 | human AFP | IgG1 | Binds to epitope 1 of AFP |
8B3-B11-E6 | human AFP | IgG2b | Binds to epitope 1 of AFP |
2C1-A10-A2 | human AFP | IgG1 | Binds to epitope 2 of AFP |
4G8-B1-D10 | human AFP | IgG1 | Binds to epitope 2 of AFP |
85-G4-C11 | human AFP | IgG1 | Binds to epitope 2 of AFP |
1C10-B10-C10 | human AFP | IgG1 | Binds to epitope 3 (not 1 or 2) of AFP |
3E9-F12-C10 | human AFP | IgG1 | Binds to epitope 3 (not 1 or 2) of AFP |
4C10-H2-D6 | human AFP | IgG1 | Binds to epitope 3 (not 1 or 2) of AFP |
6C10-A8-C1 | human AFP | IgG1 | Binds to epitope 3 (not 1 or 2) of AFP |
Return to Index |
Name | Antigen | Subclass | Comments |
2G6-11B | PE | not characterized | |
2B11-9G | PE | " | |
3A2-7C | PE | " | |
3E1-4B | PE | " | |
1D12-C3 | PE | " | |
4G1-1F | PE | " | |
2B1-4G | PE | " | |
Return to Index |
Name | Antigen | Subclass | Comments |
G | recombinant human PLC delta 1 | IgG1 | |
1C9 | " | IgG1 | |
3E8 | " | IgG1 | |
3H5 | " | IgG1 | |
5G5 | " | IgG1 | |
6A6 | " | IgG1 | |
Return to Index |
Name | Antigen | Subclass | Comments |
3G1-B1 | recombinant human PLC delta 3 | binds dominant C-teminal domain epitope | |
8B6-B9 | " | " | |
9E4-G11 | " | " | |
9E5-B6 | " | IgG1 | " |
10B11-B5 | " | IgG1 | " |
2A11-D10-D8 | N-terminal domain of PLC delta3 | binds N-terminal domain | |
8G10-C12-B12 | " | " | |
9H5-F5-B10 | " | " | |
Return to Index |
Name | Antigen | Subclass | Comments |
1E8 | recombinant E. coli beta-glucuronidase | IgG1 | good for western blots, ELISA |
3C1 | " | IgG1 | |
6D1 | " | IgG2a | |
Return to Index |
Name | Antigen | Subclass | Comments |
1B3-C1 | rhuman beta-G | IgG1 lambda | ELISA +++, Western +++, no cross rxn mouse beta-G, does not inhibit activity |
1B5-D3 | rhuman beta-G | IgG2b kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
3F2-G10 | rhuman beta-G | IgG1 kappa | ELISA +++, Western +++, no cross rxn mouse beta-G, does not inhibit activity |
3G7-H12 | rhuman beta-G | IgG1 kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
5E1-H4 | rhuman beta-G | IgG1 kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
5G11-F9 | rhuman beta-G | IgG1 kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
7E1-A12 | rhuman beta-G | IgG1 kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
7F7-F3 | rhuman beta-G | IgG2b lambda | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
7G8-B7 | rhuman beta-G | IgG2b kappa | ELISA +++, Western -, no cross rxn mouse beta-G, does not inhibit activity |
Return to Index |
Name | Antigen | Subclass | Comments |
7G7 | rmurine beta-G | rat IgG | ELISA +++, FACs +++, Western -, no cross rxn human beta-G, does not inhibit activity |
Return to Index |
Name | Antigen | Subclass | Comments |
RC1 | rRNAse | IgG1 | reacts with native RC bullfrog RNAse |
RC2 | " | IgG1 | " |
RC3 | " | IgG2b | " |
RC4 | " | IgG1 | " |
RC5 | " | IgG1 | " |
Return to Index |
Name | Antigen | Subclass | Comments |
SR-TOP-1A | rhuman topo I | IgM | ELISA +, Immunoblot +/- |
SR-TOP-2A | " | IgM | ELISA +, Immunoblot +/- |
SR-TOP-4A | " | IgG2b | ELISA +++, Immunoblot +++ |
SR-TOP-4C | " | IgG2b | ELISA +++, Immunoblot +++ |
4F2 | " | ND | ELISA -, Immunoblot + |
8D3 | " | ND | ELISA ++, Immunoblot + |
9F4 | " | ND | ELISA -, Immunoblot +/- |
Return to Index |
Name | Antigen | Subclass | Comments |
5D5-G11 | muc5 | IgG1 | reacts with human muc5 (mucin) |
6E3-G10 | " | IgG1 | " |
9B12-A2 | " | IgG1 | " |
7D6-E6 | " | IgG1 | " |
8A1-H2 | " | IgG1 | " |
Return to Index |
Name | Antigen | Subclass | Comments |
AGP3 | bG-sPEG conjugate | IgM | Specific for PEG backbone |
E11 | " | IgG1 | Specific for PEG backbone |
AGP4 | " | IgM | Specific for PEG backbone |
3.3 | " | IgG1 | Specific for PEG backbone |
6.3 | " | IgG1 | Specific for PEG backbone, high affinity |
15-2b | " | IgG2b | Specific for methoxy terminus, high affinity |
r33G | " | IgG1 | rat mAb, specific for PEG backbone, high affinity |
rAGP6 | " | IgM | rat mAb, specific for PEG backbone, high affinity |
Return to Index |
Name | Antigen | Subclass | Comments |
2A8-F11 | recombinant human tgs101 | binds to domain between aa 167-374, perinuclear and diffuse cytoplasmic immunofluorescence staining | |
3D8-H6 | " | IgG1 | binds to domain between aa 250-300, perinuclear and diffuse cytoplasmic immunofluorescence staining |
3G1-D11 | " | perinuclear immunofluorescence staining | |
6B3-G1 | " | ||
7H5-D6 | " | ||
10H12-C6 | " | IgG1 | |
Return to Index |
Name | Antigen | Subclass | Comments |
6D1-H3 | recombinant MA | p17 (gag) / HIV matrix protein | |
9G8-C5 | " | ||
9G12-D4 | " | ||
Return to Index |
Name | Antigen | Subclass | Comments |
1F4 | TAL6 DNA immunization | IgG1 | flow cytometer/ELISA |
3C6 | " | IgG1 | " |
6D6 | " | IgG1 | " |
8D10 | " | IgM | " |
9C7 | " | IgG1 | " |
10A9 | " | IgG1 | " |
10H6 | " | IgM | Western blots |
2E7 | " | IgM | dot blots / may recognize cryptic or internal epitope |
Return to Index |
Name | Antigen | Subclass | Comments |
1H10 | CaSki cells | IgG3 | reacts with human cervical and colon carcinoma |
9D5 | SiHa cells | reacts with some human cervical carcinomas | |
Return to Index |
Name | Antigen | Subclass | Comments |
RH1 | AS-30D cells | IgG2a | reacts withAS-30D rat hepatoma cells |
1C6-6C | " | IgG2a | " |
6C6-4G | " | IgG2a | " |
3F6-9B | " | IgG2a | " |
Return to Index |
Name | Antigen | Subclass | Comments |
3D5 | B16/F10 cells | IgM | reacts with B16/F10 melanoma cells (C57/BL6 mice) |
E8 | " | IgG2b | " |
E9 | " | IgG2b | " |
Return to Index |
Name | Antigen | Subclass | Comments |
1E9 | B16/BL6 cells | IgM | reacts with B16/BL6 metastatic melanoma cells (C57/BL6 mice) |
3D8 | " | IgM | " |
3F10 | " | IgM | " |
6G9 | " | IgM | " |
Return to Index |
Name | Antigen | Subclass | Comments |
AC-1 | human cells | IgG1 | reacts with most human cells |
AC-2 | " | IgG1 | " |
AC-3 | " | IgM | mAbs available up to AC-10 |
Return to Index |
Name | Antigen | Subclass | Comments |
6D8-B2 | CL1-0 human lung adenocarcinoma cells | preferentially binds CL1-0 more than CL1-5 | |
8E6-C2 | " | " | |
9F11-B1 | " | " | |
Return to Index |
Name | Antigen | Subclass | Comments |
Ly-1F4 | CL1-5 human lung adenocarcinoma cells | IgG1 | binds CD13, partially inhibits aminopeptidase activity |
Ly-1G9 | " | IgG1 | binds EphA2 |
Ly-2A2 | " | IgG1 | binds VLA-3 alpha (integrin alpha 3) |
Ly-3C1 | " | IgG1 | binds EphA2 |
Ly-3E4 | " | IgG1 | preferentially binds CL1-5 more than CL1-0 |
Ly-3F7 | " | IgG2b | binds EphA2 |
Ly-4B8 | " | IgG2b | binds CD13, goes not inhibit aminopeptidase activity |
Ly-4F5 | " | IgG1 | preferentially binds CL1-5 more than CL1-0 |
Ly-5D7 | " | IgG1 | " |
Ly-6F10 | " | IgG1 | " |
Ly-7F10 | " | IgG1 | " |
Ly-8G6 | " | IgG1 | " |
Ly-9A1 | " | IgG1 | binds CD13, partially inhibits aminopeptidase activity |
Ly-9F7 | " | IgG2b | preferentially binds CL1-5 more than CL1-0 |
Ly-10D5 | " | IgG1 | " |
Ly-10F3 | " | IgG1 | " |
Return to Index |
Name | Antigen | Subclass | Comments |
5G11-G3-B5 | JEV | IgG2b | binds JEV-E protein |
5E11-D9-G6 | " | IgG2b | " |
Return to Index |
Name | Antigen | Subclass | Comments |
2BS | infected cells | IgG3 | detects micoplasma infected cells |
4BF | " | IgG1 | " |
5BFII | " | IgG3 | " |
6BF | " | IgG2b | " |
7BF3 | " | IgG1 | " |
8BF | " | IgG2b | " |
10BFII | " | IgM | " |
11BFII | " | IgM | " |
12BFII | " | IgM | " |
17BFII | " | IgM | " |
18BFII | " | IgM | " |
Return to Index |